Moxifloxacin improves long-term prognosis in patients with infectious-dependent exacerbation of chronic bronchitis

1. Anthoniseti N.R., Manfreda J., Warren С.P. et al. Antibiotic therapy in acute exacerbation of chronic obstructive pulmonary disease. Ann. Intern. Med. 1987; 106: 196-204.

2. Bauer Т., Landen H. Rapid resolution of symptoms with moxifloxacin therapy in 7223 patients with acute exacerbation of chronic bronchitis. Comparison with prior macrolide therapy. Clin. Drug Invest. 2002; 22 (10): 641-651.

3. Chodosh S., Schreurs A., Siamai G. et al. Efficacy of oral ciprofloxacin vs. clarithromycin for treatment of acute bacterial exacerbations of chronic bronchitis. Clin. Infect. Dis. 1998; 27: 730-738.

4. DeAbate C.A., Mathew C.P., Warner J.H. et al. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis. Respir. Med. 2000; 94: 1029-1037.

5. Hoban D., Felmingham D. The PROTECT surveillance study: antimicrobial susceptibility of H.influenzae and M.catarrhalis from community-acquired respiratory tract infections. J. Antimicrob. Chemother. 2002; 50 (suppl. 1): 49-59.

6. Moxon E.R., Murphy T.F. Haemophilus influenzae. In: Mandell G.L., Bennett J.E., Dolin R., eds. Principles and practice of infectious diseases. Philadelphia: Churchill Livingstone; 2000; vol.2: 2369-2378.

7. Murhy T.F., Sethi S. Bacterial infection in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 1992; 146: 1067-1083.

8. Pechere J.-C., Lacey L. Optimizing economic outcomes in antibiotic therapy of patients with acute bacterial exacerbation of chronic bronchitis. J. Antimicrob. Chemother. 2000; 45 (topic T2): 19-24.

9. Saint S., Bent S., Vittinghoff E. et al. Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis. J.A.M.A. 1995; 273: 957-960.

10. Saravolatz L.D ., Leggett J. Gatifloxacin, gemifloxacin, and moxifloxacin: the role of 3 newer fluoroquinolones. Clin. Infect. Dis. 2003; 37: 1210-1215.

11. Tran J.Q., Ballow C.H., Forrest A. et al. Comparison of the abilities of grepafloxacin and clarithromycin to eradicate potential bacterial pathogens from the sputa of patients with chronic bronchitis: influence of pharmacokinetic and pharmacodynamic variables. J. Antimicrob. Chemother. 2000; 45 (topic T2): 9-17.

12. Wilson R., Jones P., Schaberg T. et al. A clinical and outcomes assessment of the management of acute exacerbation of chronic bronchitis (AECB): the M O SAIC study. Eur. Respir. J. 2003; 22 (suppl.45): abstr. P3371.

13. Wilson R., Allegra L., Huchon G. et al. The MOSAIC study: prognostic subgroup analysis of the efficacy of moxifloxacin (M FX ) compared to standard antibiotic treatment (STD) in acute exacerbations of chronic bronchitis (A EC B). In: 43rd ICAAC. Chicago; 2003. abstr. L-1593.